Literature DB >> 3885218

Expression of p21ras in fresh primary and metastatic human colorectal tumors.

G E Gallick, R Kurzrock, W S Kloetzer, R B Arlinghaus, J U Gutterman.   

Abstract

Activation of the cellular oncogene ras has been implicated in many types of human malignancies. In this study, the relative levels of p21 protein product of ras (p21ras) in primary and metastatic colon tumors were compared to those in adjacent normal tissues. Nine of the 17 primary tumors had substantially elevated levels of p21ras with respect to adjacent normal tissues. Eight of these tumors were from Dukes' B and C stages. Four of the five tumors classified as "D" stage (in which distant metastases are present) did not show elevated levels of p21ras. In metastases from primary colon tumors, nine of nine were considerably reduced in p21ras expression regardless of the site of metastasis. These data suggest that elevation of p21ras may be a common event in early stages of colon tumors, and tumor progression may lead to a more autonomous population of cells in which other growth factors supplant the role of this protein.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3885218      PMCID: PMC397359          DOI: 10.1073/pnas.82.6.1795

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Mechanism of activation of a human oncogene.

Authors:  C J Tabin; S M Bradley; C I Bargmann; R A Weinberg; A G Papageorge; E M Scolnick; R Dhar; D R Lowy; E H Chang
Journal:  Nature       Date:  1982-11-11       Impact factor: 49.962

2.  Monoclonal antibodies to the transformation-specific glycoprotein encoded by the feline retroviral oncogene v-fms.

Authors:  S J Anderson; M Furth; L Wolff; S K Ruscetti; C J Sherr
Journal:  J Virol       Date:  1982-11       Impact factor: 5.103

3.  Transforming genes of human bladder and lung carcinoma cell lines are homologous to the ras genes of Harvey and Kirsten sarcoma viruses.

Authors:  C J Der; T G Krontiris; G M Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

4.  Metastatic RAW117 lymphosarcoma as a model for malignant-normal cell interactions. Possible roles for cell surface antigens in determining the quantity and location of secondary tumors.

Authors:  G L Nicolson; J J Mascali; E J McGuire
Journal:  Oncodev Biol Med       Date:  1982

5.  A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene.

Authors:  E P Reddy; R K Reynolds; E Santos; M Barbacid
Journal:  Nature       Date:  1982-11-11       Impact factor: 49.962

6.  Characterization of a human colon/lung carcinoma oncogene.

Authors:  M S McCoy; J J Toole; J M Cunningham; E H Chang; D R Lowy; R A Weinberg
Journal:  Nature       Date:  1983-03-03       Impact factor: 49.962

7.  Altered gene products are associated with activation of cellular rasK genes in human lung and colon carcinomas.

Authors:  C J Der; G M Cooper
Journal:  Cell       Date:  1983-01       Impact factor: 41.582

8.  Monoclonal antibodies to the p21 products of the transforming gene of Harvey murine sarcoma virus and of the cellular ras gene family.

Authors:  M E Furth; L J Davis; B Fleurdelys; E M Scolnick
Journal:  J Virol       Date:  1982-07       Impact factor: 5.103

9.  Cellular transforming genes.

Authors:  G M Cooper
Journal:  Science       Date:  1982-08-27       Impact factor: 47.728

10.  Hypomethylation of ras oncogenes in primary human cancers.

Authors:  A P Feinberg; B Vogelstein
Journal:  Biochem Biophys Res Commun       Date:  1983-02-28       Impact factor: 3.575

View more
  46 in total

Review 1.  Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview.

Authors:  A H Wyllie
Journal:  Cancer Metastasis Rev       Date:  1992-09       Impact factor: 9.264

2.  Biochemical characterization of Artemia ras p21.

Authors:  A Gandarillas; J Renart; M Quintanilla
Journal:  Mol Cell Biochem       Date:  1992-05-13       Impact factor: 3.396

3.  A short, highly repetitive element in intron -1 of the human c-Ha-ras gene acts as a block to transcriptional readthrough by a viral promoter.

Authors:  N F Lowndes; P Bushel; L Mendelsohn; J Wu; M Y Yen; M Allan
Journal:  Mol Cell Biol       Date:  1990-09       Impact factor: 4.272

4.  Immunocytochemical detection of p21ras expression in fresh human leukaemic cells and cell lines.

Authors:  A Neubauer; H Herbst; C Rochlitz; W Siegert; C A Schmidt; D Huhn
Journal:  Blut       Date:  1989-11

5.  Induction of urokinase activity and malignant phenotype in bladder carcinoma cells after transfection of the activated Ha-ras oncogene.

Authors:  G Brunner; J Pohl; L J Erkell; A Radler-Pohl; V Schirrmacher
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

6.  Ras levels and metalloproteinase activity in normal versus neoplastic rat mammary tissues.

Authors:  M Ballin; A R Mackay; J L Hartzler; A Nason; M D Pelina; U P Thorgeirsson
Journal:  Clin Exp Metastasis       Date:  1991 Mar-Apr       Impact factor: 5.150

7.  Monoclonal antibody specific for an activated RAS protein.

Authors:  W P Carney; D Petit; P Hamer; C J Der; T Finkel; G M Cooper; M Lefebvre; H Mobtaker; R Delellis; A S Tischler
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

Review 8.  A model to account for the effects of oncogenes, TPA, and retinoic acid on the regulation of genes involved in metastasis.

Authors:  J Pohl; A Radler-Pohl; V Schirrmacher
Journal:  Cancer Metastasis Rev       Date:  1988-12       Impact factor: 9.264

9.  A comparison of tumor-related antigens in male and female breast cancer.

Authors:  J Lundy; Y Mishriki; M V Viola; S Chao; B Kasa; S Oravez; A Schuss
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

10.  Expression of p21ras in normal and malignant human tissues: lack of association with proliferation and malignancy.

Authors:  P G Chesa; W J Rettig; M R Melamed; L J Old; H L Niman
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.